Prostate Cancer Clinical Trial

Clinical Trial Finder Prostate Cancer Trials

A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer

See Locations Near You

Summary

The primary purpose of this study is to determine the safest dose of ZD4054 (Zibotentan)in men with prostate cancer

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Men 18 years & older
Confirmed diagnosis of prostate cancer with bone metastases

Exclusion Criteria:

No more than 2 prior chemotherapy regimens
No radiation, chemotherapy or bisphosphonates in the past 4 weeks

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

22

Study ID:

NCT00055471

Recruitment Status:

Completed

Sponsor:

AstraZeneca

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Research Site
Cleveland Ohio, 44195, United States
Research Site
Madison Wisconsin, , United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

22

Study ID:

NCT00055471

Recruitment Status:

Completed

Sponsor:


AstraZeneca

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider